Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep591 | Endocrine-Related Cancer | ECE2022

Atypical presentation of recurrence following previous resected Primary Parathyroid Carcinoma- dilemmas in follow up of this rare malignancy

Khan Haris , Nawaz Maimoona , Malik Isha

Introduction: Parathyroid cancer is a rare endocrine malignancy and constitutes 0.005% of all cancers. It can recur in 50% of cases. The first recurrence commonly occurs within 3 years of the original diagnosis. Hypercalcaemia is the main cause of morbidity and mortality. We present a case of a 62-year-old male patient who had an atypical lung nodule recurrence with normal calcium and PTH levels, six years following resection of a functioning parathyroid cancer.<p class="a...

ea0081ep224 | Calcium and Bone | ECE2022

A pathological fracture of the femur and multiple pelvic osteolytic lesions mimicking bone metastases as the first presentation of Primary Hyperparathyroidism

Khan Haris , Nawaz Maimoona , Dang Cuong , Malik Isha

Introduction: Pathological fractures are uncommon in young patients and raise concern about malignancy. Brown tumour (osteitis fibrosa cystica) is a rare benign resorptive bone lesion reported in approximately 3% of patients with primary hyperparathyroidism (PHPT). These have become uncommon in contemporary practice and have the potential to be misdiagnosed because of radiological similarities to other bone diseases especially malignancy.We present a case where the first prese...

ea0038p88 | Clinical practice/governance and case reports | SFEBES2015

Haemofiltration as a treatment option in refractory life-threatening diabetic ketoacidosis

Agha Adnan , Nawaz Sarfraz , Saleem Mazhar , Jones Sharon , Ahmed Adeeba

Background: Treating life-threatening diabetic ketoacidosis (DKA) with a pH of <6.9 is extremely challenging and often refractory to treatment using standard fixed dose insulin DKA management protocols which may not work effectively at this low pH because of increased insulin resistance. I.v. bicarbonate (HCO3) use in this situation can be considered but remains controversial due to the risk of significant side effects as well as limited evidence in literature. ...

ea0034p57 | Clinical practice/governance and case reports | SFEBES2014

Fixed dose radioactive iodine treatment for hyperthyroidism: experience of a district general hospital

Manjunatha Rashmi , Harris Katherine , Nawaz Sarfraz , Mahto Rajni , Horrocks Peter

Background: The short- and long-term clinical outcome of patients receiving radioactive iodine treatment (RAI) differs in various studies. There is little consensus regarding the most appropriate dose of RAI to be administered. The range of activities currently prescribed varies between 200 and 800 MBq, with majority of patients receiving 400–600 MBq. In our centre, all patients receive a standard fixed dose of 400 MBq.Aim: To assess the cure rate w...

ea0073aep439 | General Endocrinology | ECE2021

A case report of cerebral salt wasting incorrectly diagnosed as the syndrome of inappropriate antidiuretic hormone secretion

Qayum Mohammed , Banwaith Tavlene , Nawaz Ghulam , Acharya Jayashekara , Sudarshan Veena

Cerebral salt wasting (CSW) occurs as the result of injury to the central nervous system and is most commonly found among those who have experienced a traumatic brain injury (TBI). Although incidence is varied, it has been reported to be as high as 30% within the patient population presenting to hospital with a TBI. CSW causes hyponatremia with concurrent hypovolemia and increased sodium within urine despite normal renal function. Because of its rare nature, CSW is often misdi...

ea0099ep450 | Pituitary and Neuroendocrinology | ECE2024

Routine monitoring for acromegaly-associated complications and recurrence: a single-centre audit

Nawaz Asif , Williams David , Guy Fiona , Min Thinzar , Yin Win

Introduction: Endocrine society guidelines advocate early colonoscopy and monitoring for acromegaly-associated complications and recurrence. We aimed to establish whether people with acromegaly under our care received appropriate monitoring.Methods: Patients under follow-up with acromegaly diagnosed 1989-2021 were included. Electronic health records were accessed for clinic letters, colonoscopy reports, blood and imaging results from the diagnosis to rec...

ea0099ep451 | Thyroid | ECE2024

Thyroxine intolerance: a rare but significant clinical entity

Nawaz Asif , Williams David , Taylor Peter , Min Thinzar , Yin Win

Introduction: Levothyroxine, the standard therapy for hypothyroidism, is usually well tolerated and very few cases of true allergy to levothyroxine have been reported to date. Here we report two cases of rare occurrence of levothyroxine allergy.Case 1: A 56-year-old woman with no previous history of allergies started levothyroxine post-thyroidectomy for Graves’ disease. She developed facial flushing and urticarial rash within 15 minutes of the first...

ea0090p149 | Pituitary and Neuroendocrinology | ECE2023

Is a 20% decrease in free T4 (fT4) levels a reliable marker of secondary hypothyroidism in patients with non-functioning pituitary macroadenoma (NFPA)?

McLaren David , Mitchell Ellen , Z Safdar Nawaz , Gibbons Stephen , D Murray Robert

Background: Central hypothyroidism can be difficult to diagnose as TSH values often reside within the normal range. The Endocrine Society clinical guideline for hormone replacement in hypopituitarism suggests levothyroxine is indicated for treatment of secondary hypothyroidism where fT4 levels decrease by ≥20%. To determine the reliability of this biochemical marker of secondary hypothyroidism we evaluated evolution of TFTs over time within a cohort of NFPA.<p class=...

ea0065p58 | Adrenal and Cardiovascular | SFEBES2019

Safe withdrawal of corticosteroids after prolonged use: a call for a national protocol

Nawaz Zahrah , Sorungbe Adebola O , Rajkanna Jeyanthy , Seechurn Shivshankar B , Sagi Satyanarayana V , Oyibo Samson O

Introduction: Prolonged therapy with high-dose corticosteroids (≥ 7.5 mg Prednisolone or 1–1.5 mg Dexamethasone daily) can result in adrenal atrophy and hypofunction. Abrupt withdrawal of corticosteroids after prolonged use can lead to adrenal insufficiency, corticosteroid withdrawal symptoms or a relapse of the initial disease. There are several in-house protocols for safe corticosteroid dose tapering but a national protocol is required.Our p...

ea0065p149 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Prolonged supervised fast for insulinoma – an experience in a District General Hospital Trust

Khan Haris , Nawaz Maimoona , Arul-Devah Vilashini , Ashraf Fahad Hassan , Pichaipillai Lakshminarayanan

Introduction: Insulinoma a neuroendocrine tumour is diagnosed by inappropriately raised Insulin concentrations during a spontaneous or induced episode of hypoglycaemia. A provocative 72-h supervised fast is done to evaluate suspected inappropriate insulin secretion. Our aim is to see if it is feasible for a shorter duration of fast is enough to confirm Insulinoma.Method and results: In our Trust we analysed retrospectively in the last 10 years, ...